019IC - Refractory Overactive Bladder: How to Select Third-Line Therapies and Optimize Outcomes

Friday, April 28, 2023

4:00 PM – 6:00 PM CST

Location: S102C

Instructional Course Director(s)

KK

Kathleen Kobashi, MD,MBA

Chair, Department of Urology
Houston Methodist Hospital

Instructional Course Faculty(s)

David Ginsberg, MD

USC Institute of Urology
SV

Sandip Vasavada, MD

Cleveland Clinic Glickman Urological Institute and Lerner College of Medicine

Course Description: Upon completion, participants will be familiar with third-line therapies available to treat refractory overactive bladder (OAB), including the pros and cons of each option, the current data regarding outcomes to facilitate proper patient counseling and optimal techniques to maximize the success of the various therapies. The case-based format will provide real-world scenarios by which to learn about the implementation of successful third-line options. The course will provide some dedicated focus to tips and tricks regarding the technical aspects of these options and the logistical implementation of them into a busy practice.

Learning Objectives:

Describe the various third-line therapies available to treat refractory OAB and discuss the pros and cons of each of the third-line therapies available to treat refractory OAB.
Explain the current data regarding outcomes of percutaneous tibial nerve stimulation, onabotulinumtoxinA and sacral neuromodulation for treatment of refractory OAB.
Outline how to perform percutaneous tibial nerve stimulation.
Report how to perform onabotulinumtoxinA injections in the office or outpatient setting.
Review techniques in optimal lead placement for sacral neuromodulation, programming and troubleshooting.
Implement systems-based factors to facilitate optimal and efficient implementation of the various third-line therapies.
Consider scripting utilizing "friendly" language to maximize patient understanding of their options and minimize patient anxiety about the options.